GSK Asks 3rd Circ. To Ignore Prior Ruling In Wellbutrin Case
GlaxoSmithKline PLC urged the Third Circuit on Wednesday not to consider its recent ruling in a product liability case over the drug Fosamax when deciding whether or not to revive a...To view the full article, register now.
Already a subscriber? Click here to view full article